PCM
AVNS

Prelude Capital Management’s Avanos Medical AVNS Stock Holding History

Prelude Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86M Buy
115,133
+101,247
+729% +$2.37M 0.21% 121
2026
Q1 		$195K Sell
13,886
-19,881
-59% -$268K 0.01% 923
2025
Q4 		$379K Buy
33,767
+13,030
+63% +$149K 0.03% 668
2025
Q3 		$240K Sell
20,737
-3,947
-16% -$46.2K 0.02% 848
2025
Q2 		$302K Buy
24,684
+3,984
+19% +$50.1K 0.03% 610
2025
Q1 		$297K Buy
20,700
+8,241
+66% +$129K 0.02% 715
2024
Q4 		$198K Buy
+12,459
New +$247K 0.01% 1000
2024
Q1 		– Sell
-14,593
Closed -$327K – 1317
2023
Q4 		$327K Buy
14,593
+4,431
+44% +$91.5K 0.02% 699
2023
Q3 		$205K Buy
+10,162
New +$230K 0.01% 888
2020
Q4 		– Sell
-2,320
Closed -$77K – 1300
2020
Q3 		$77K Sell
2,320
-900
-28% -$28.8K ﹤0.01% 995
2020
Q2 		$95K Buy
3,220
+20
+0.6% +$579 0.01% 971
2020
Q1 		$86K Buy
+3,200
New +$95.6K 0.01% 635
2019
Q1 		– Sell
-7,042
Closed -$315K – 1751
2018
Q4 		$315K Buy
7,042
+1,793
+34% +$93.9K 0.02% 594
2018
Q3 		$360K Buy
+5,249
New +$338K 0.02% 620
2016
Q4 		– Sell
-14,699
Closed -$509K – 1538
2016
Q3 		$509K Buy
14,699
+5,547
+61% +$194K 0.05% 310
2016
Q2 		$298K Buy
9,152
+2,352
+35% +$72K 0.04% 394
2016
Q1 		$195K Buy
6,800
+4,100
+152% +$109K 0.03% 561
2015
Q4 		$90K Buy
+2,700
New +$84K 0.01% 846
2015
Q3 		– Sell
-1,000
Closed -$41K – 1473
2015
Q2 		$41K Buy
+1,000
New +$44.9K 0.01% 1214

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Prelude Capital Management's AVNS Position: Q2 2026 in Review

Prelude Capital Management increased its Avanos Medical (AVNS) stake by 729% in Q2 2026, buying an estimated $2.37M and bringing the position to 115,133 shares worth $2.86M. The position accounts for 0.21% of the portfolio, ranked #121.

Prelude Capital Management first reported a position in AVNS in Q2 2015 and has held it in 19 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Prelude Capital Management held 115,133 shares of Avanos Medical worth $2.86M as of Q2 2026.
  • Prelude Capital Management bought 101,247 Avanos Medical shares in Q2 2026, an estimated $2.37M.
  • Avanos Medical made up 0.21% of Prelude Capital Management's portfolio in Q2 2026, its #121 holding.
  • Prelude Capital Management first reported a position in Avanos Medical in Q2 2015 and has held it in 19 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.